(Q44313214)

1 December 2017

title

Changes in serum HDL and LDL cholesterol in patients with Paget's bone disease treated with pamidronate (English)

1 reference

1 December 2017

1 reference

Montagnani A

1

1 reference

1 December 2017

Gonnelli S

2

1 reference

1 December 2017

Cepollaro C

3

1 reference

1 December 2017

Campagna MS

4

1 reference

1 December 2017

Franci MB

5

1 reference

1 December 2017

Pacini S

6

1 reference

1 December 2017

Gennari C

7

1 reference

1 December 2017

publication date

1 January 2003

1 reference

1 December 2017

1 reference

1 December 2017

volume

32

1 reference

1 December 2017

issue

1

1 reference

1 December 2017

page(s)

15-19

1 reference

Chronic intravenous aminobisphosphonate therapy increases high-density lipoprotein cholesterol and decreases low-density lipoprotein cholesterol.

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900924-9

7 January 2021

The novel cholesterol-lowering drug SR-12813 inhibits cholesterol synthesis via an increased degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900924-9

7 January 2021

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900924-9

7 January 2021

Plasma lipids and cardiovascular risk: a POSCH report. Program on the Surgical Control of the Hyperlipidemias

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900924-9

7 January 2021

HDL-cholesterol as a marker of coronary heart disease risk: the Québec cardiovascular study.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900924-9

7 January 2021

Clodronate and liposome-encapsulated clodronate are metabolized to a toxic ATP analog, adenosine 5'-(beta, gamma-dichloromethylene) triphosphate, by mammalian cells in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900924-9

7 January 2021

Time-dependent changes in biochemical bone markers and serum cholesterol in ovariectomized rats: effects of raloxifene HCl, tamoxifen, estrogen, and alendronate

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900924-9

7 January 2021

Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900924-9

7 January 2021

A clinical approach to diagnosis and management of Paget's disease of bone

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900924-9

7 January 2021

A randomized, double-blind comparison of risedronate and etidronate in the treatment of Paget's disease of bone. Paget's Risedronate/Etidronate Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900924-9

7 January 2021

Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900924-9

7 January 2021

Pamidronate in the treatment of Paget's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900924-9

7 January 2021

Paget's disease of bone.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900924-9

7 January 2021

Farnesyl pyrophosphate synthase is the molecular target of nitrogen-containing bisphosphonates

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900924-9

7 January 2021

The role of geranylgeranylation in bone resorption and its suppression by bisphosphonates in fetal bone explants in vitro: A clue to the mechanism of action of nitrogen-containing bisphosphonates

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900924-9

7 January 2021

10.1016/S8756-3282(02)00924-9

Identifiers

DOI

1 reference

1 December 2017

1 reference